MAIA Biotechnology (MAIA) News Today $1.80 -0.02 (-0.83%) As of 09:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock MAIA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 3.5% - What's Next?October 8 at 3:27 AM | marketbeat.comMAIA Biotechnology to initiate digital asset treasury strategyOctober 7 at 5:19 PM | msn.comMAIA Biotechnology Adopts New Digital Asset StrategyOctober 7 at 5:19 PM | msn.comCancer drug maker takes sudden pivot into cryptoOctober 7 at 5:19 PM | msn.comMAIA Biotechnology, Inc. Approves Up to 90% Liquid Asset Holdings in Cryptocurrencies as Part of New Digital Asset Treasury StrategyOctober 7 at 9:11 AM | quiverquant.comQMAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto AssetsOctober 7 at 8:47 AM | globenewswire.comStan Smith Purchases 19,230 Shares of MAIA Biotechnology (NYSEAMERICAN:MAIA) StockOctober 3, 2025 | insidertrades.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Director Stan Smith Acquires 19,230 SharesOctober 2, 2025 | marketbeat.comMAIA Biotechnology Announces $2.25M Private Placement DealOctober 1, 2025 | msn.comMAIA Biotechnology announces $2.25M private placementSeptember 29, 2025 | msn.comMAIA Biotechnology, Inc. Announces $2.25 Million Private Placement of Common Stock and WarrantsSeptember 29, 2025 | quiverquant.comQMAIA Biotechnology Announces $2.25 Million Private PlacementSeptember 29, 2025 | globenewswire.comMAIA Biotechnology Secures NIH Grant for THIO-101 TrialSeptember 25, 2025 | msn.comMAIA Biotechnology awarded $2.3M grant by NIH for THIO-101September 25, 2025 | msn.comMAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting AgentSeptember 24, 2025 | globenewswire.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Up 1.8% - What's Next?September 17, 2025 | marketbeat.comMAIA Biotechnology Updates Business Presentation OnlineSeptember 13, 2025 | msn.comMaia’s NSCLC immunotherapy secures Phase II efficacy winSeptember 12, 2025 | msn.comMAIA Biotechnology highlights efficacy data from THIO-101 Phase 2 trialSeptember 11, 2025 | msn.comMAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung CancerSeptember 11, 2025 | markets.businessinsider.comMAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung CancerSeptember 5, 2025 | globenewswire.comMAIA Biotechnology announces publication of interim clinical data on THIO-101August 28, 2025 | msn.comMAIA Biotechnology, Inc. Announces Publication of Phase 2 THIO-101 Clinical Trial Findings in Scientific Journal CellsAugust 27, 2025 | quiverquant.comQMAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal CellsAugust 27, 2025 | globenewswire.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Up 3.3% - Here's What HappenedAugust 25, 2025 | marketbeat.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Sees Large Increase in Short InterestAugust 21, 2025 | marketbeat.comDiamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)August 18, 2025 | globenewswire.comMAIA Biotechnology granted European patent for telomere-targeting agentsAugust 13, 2025 | msn.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 2.4% - What's Next?July 31, 2025 | marketbeat.comMaia Biotechnology shares jump after FDA awards Fast Track statusJuly 28, 2025 | msn.comMaia Biotechnology stock soars after FDA grants Fast Track designationJuly 28, 2025 | au.investing.comMAIA Biotechnology Shares Rise After FDA Fast Track Designation for AteganosineJuly 28, 2025 | marketwatch.comMAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung CancerJuly 28, 2025 | finance.yahoo.comMAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung CancerJuly 28, 2025 | businesswire.comMaia Biotechnology stock soars after publishing promising preclinical dataJuly 17, 2025 | investing.comMAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer TherapyJuly 17, 2025 | businesswire.comMAIA Biotechnology Announces First Patient Dosed in ... - MorningstarJuly 11, 2025 | morningstar.comMMAIA Biotechnology doses first patient in expansion of Phase II lung cancer trialJuly 10, 2025 | finance.yahoo.comMAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung CancerJuly 9, 2025 | finance.yahoo.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Up 0.5% - Still a Buy?July 9, 2025 | marketbeat.comMAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 CongressJuly 1, 2025 | finance.yahoo.comMAIA Biotechnology appoints HCC experts to scientific advisory boardJune 26, 2025 | uk.investing.comMAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory BoardJune 24, 2025 | finance.yahoo.comMAIA Biotechnology partners with Roche for cancer treatment studiesJune 20, 2025 | uk.investing.comMAIA Biotechnology, Roche sign supply agreement for cancer therapiesJune 19, 2025 | finance.yahoo.comMAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock SoarsJune 18, 2025 | msn.comMAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer TherapiesJune 18, 2025 | businesswire.comMAIA Biotechnology to Present at BIO International Convention 2025June 10, 2025 | businesswire.comStan Smith Acquires 33,333 Shares of MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) StockJune 6, 2025 | insidertrades.comMaia Biotechnology stock rises following positive trial resultsJune 5, 2025 | in.investing.com Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MAIA Media Mentions By Week MAIA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAIA News Sentiment▼1.000.63▲Average Medical News Sentiment MAIA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAIA Articles This Week▼92▲MAIA Articles Average Week Get the Latest News and Ratings for MAIA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MAIA Biotechnology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ACRS News EPRX News CHRS News BIOA News ZURA News MDWD News SXTC News FTLF News DERM News SCLX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:MAIA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MAIA Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
